Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 1, Number 2, 1 August 2001


Selectively Replicating Adenoviruses for Oncolytic Therapy
pp. 85-107(23)
Authors: Yoon, T-k.; Shichinohe, T.; Laquerre, S.; Kasahara, N.


Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations
pp. 109-119(11)
Authors: Rodriguez-Garcia, A.; Sanchez-Martin, M.; Perez-Losada, J.; Perez-mancera, P.A.; Sagrera-Aparisi, A.; Gutierrez-Cianca, N.; Cobaleda, C.; Sanchez-Garcia, I.


Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents
pp. 129-140(12)
Authors: Ghosh, S.; Liu, X.; Zheng, Y.; Uckun, F.M.


Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy
pp. 141-153(13)
Authors: Focher, F.; Spadari, S.


Microarrays: Spotlight on Gene Function and Pharmacogenomics
pp. 155-175(21)
Authors: Nees, M.; Woosworth, C.D.


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more